ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Pascal Biosciences Inc

Pascal Biosciences Inc (PAS)

0,015
0,00
( 0,00% )
Aktualisiert: 01:00:00

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,015
Gebot
0,03
Fragen
0,03
Volumen
-
0,00 Tagesbereich 0,00
0,015 52-Wochen-Bereich 0,015
Marktkapitalisierung
Handelsende
0,015
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
38.140.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,95
Gewinn pro Aktie (EPS)
-0,01
Erlöse
672k
Nettogewinn
-400k

Über Pascal Biosciences Inc

Sektor
Blank Checks
Branche
Pharmaceutical Preparations
Hauptsitz
Seattle, Washington, USA
Gegründet
2011
Pascal Biosciences Inc is listed in the Blank Checks sector of the TSX Venture Börse with ticker PAS. The last closing price for Pascal Biosciences was $0,02. Over the last year, Pascal Biosciences shares have traded in a share price range of $ 0,015 to $ 0,015.

Pascal Biosciences currently has 38.140.000 shares in issue. The market capitalisation of Pascal Biosciences is $572.100,00 . Pascal Biosciences has a price to earnings ratio (PE ratio) of -0.95.

PAS Neueste Nachrichten

UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and its Non-Brokered Private Placement to Raise up to $900,000 with $0.10 Units – Video Available on Investmentpitch.com

VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious...

InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Cancer Institute Grant for its Acute Lymphoblastic Leukemia Program – Video Available on Investmentpitch.com

VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious...

SōRSE Technology Partners with & Acquires Part of Cancer Research Group Pascal Biosciences for Cannabinoid Research Programs

Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) has entered into a Term Sheet with SōRSE Technology (“SōRSE”) to develop Pascal’s cannabinoid programs. Investing in and financially supporting...

PASCAL BIOSCIENCES ANNOUNCES PRIVATE PLACEMENT AND POTENTIAL TRANSACTION WITH SŌRSE TECHNOLOGY FOR CANNABINOID RESEARCH PROG...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:...

Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia

VANCOUVER, British Columbia and SEATTLE and DAEJON, Korea, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and Y-Biologics (together the “Companies”) today...

Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment

VANCOUVER, British Columbia, and SEATTLE, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today revealed the mechanism whereby cannabinoids may...

Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceuticals Summit

VANCOUVER, British Columbia and SEATTLE, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”). Pascal announces that Dr. Patrick Gray, CEO, will...

Pascal Biosciences to Present at 2019 BIO International Convention

Vancouver, BRITISH COLUMBIA and SEATTLE, May 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today...

Pascal Biosciences Announces Formation of Clinical Advisory Board

VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today...

Pascal Biosciences Provides Corporate Update for First Quarter of 2019

VANCOUVER, British Columbia and SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.0150.0150.01500CS
4000.0150.0150.01500CS
12000.0150.0150.01500CS
26000.0150.0150.01500CS
52000.0150.0150.01500CS
156-0.045-750.060.10.015102120.05078086CS
260-0.08-84.21052631580.0950.450.015326140.12039869CS

PAS - Frequently Asked Questions (FAQ)

What is the current Pascal Biosciences share price?
The current share price of Pascal Biosciences is $ 0,015
How many Pascal Biosciences shares are in issue?
Pascal Biosciences has 38.140.000 shares in issue
What is the market cap of Pascal Biosciences?
The market capitalisation of Pascal Biosciences is CAD 572,1k
What is the 1 year trading range for Pascal Biosciences share price?
Pascal Biosciences has traded in the range of $ 0,015 to $ 0,015 during the past year
What is the PE ratio of Pascal Biosciences?
The price to earnings ratio of Pascal Biosciences is -0,95
What is the cash to sales ratio of Pascal Biosciences?
The cash to sales ratio of Pascal Biosciences is 0,57
What is the reporting currency for Pascal Biosciences?
Pascal Biosciences reports financial results in CAD
What is the latest annual turnover for Pascal Biosciences?
The latest annual turnover of Pascal Biosciences is CAD 672k
What is the latest annual profit for Pascal Biosciences?
The latest annual profit of Pascal Biosciences is CAD -400k
What is the registered address of Pascal Biosciences?
The registered address for Pascal Biosciences is 1900 AIRPORT WAY S, SUITE 201, SEATTLE, WASHINGTON, 98134
What is the Pascal Biosciences website address?
The website address for Pascal Biosciences is www.nevisbrands.com
Which industry sector does Pascal Biosciences operate in?
Pascal Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ACAP.PAtlas One Capital Corporation
$ 0,03
(100,00%)
10,1k
TVITVI Pacific Inc
$ 0,01
(100,00%)
4k
ETUE2gold Inc
$ 0,01
(100,00%)
2,5k
NKW.HOceanic Wind Energy Inc
$ 0,055
(57,14%)
90,1k
VRYPetro Victory Energy Corp
$ 1,50
(51,52%)
1,02k
PPMPacific Imperial Mines Inc
$ 0,005
(-66,67%)
4,67M
CCDCascadero Copper Corporation
$ 0,005
(-50,00%)
19k
FUNDKatipult Technology Corp
$ 0,005
(-50,00%)
95,44k
BNZBonanza Mining Corporation
$ 0,01
(-50,00%)
20k
ADEAdex Mining Inc
$ 0,005
(-50,00%)
90k
AUUAALUULA Composites Inc
$ 0,045
(-10,00%)
8,64M
QNCQuantum Emotion Corp
$ 0,52
(19,54%)
5,36M
SSESilver Spruce Resources Inc
$ 0,005
(0,00%)
4,97M
PPMPacific Imperial Mines Inc
$ 0,005
(-66,67%)
4,67M
GPUSAlset AI Ventures Inc
$ 0,12
(26,32%)
3,68M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock